SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : BMRN - Biomarin Pharmaceutical Inc.

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: jeeee43/25/2010 11:56:24 AM
   of 18
 
Bona fide offer for BMRN? Director quits over it
NEW YORK (Dow Jones)--
BioMarin Pharmaceutical Inc
. (BMRN) shares rose to a 52-week high Thursday after a board member's resignation sparked talk that the biopharmaceutical company may have received a takeover offer.
In a regulatory filing posted after the bell Wednesday, the company said the board member, Joseph Klein III, wrote in his resignation letter that Chief Executive Jean-Jacques Bienaim received a "bona fide offer" fr6om a third party, and failed to share this offer with the board for consideration.
Despite the company's denials that it received such an offer, BioMarin shares were up 6.6% to $24.52 in recent trading as investors appeared to be speculating that the company has received some form of an offer. The stock earlier rose as high as $24.98, a level it hasn't traded above since October 2008.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext